Navigation Links
Conseco to Implement Systems and Operational Solution From Long Term Care Group
Date:11/28/2007

ct of 1995. Forward-looking statements typically are identified by the use of terms such as "anticipate," "believe," "plan," "estimate," "expect," "project," "intend," "may," "will," "would," "contemplate," "possible," "attempt," "seek," "should," "could," "goal," "target," "on track," "comfortable with," "optimistic" and similar words, although some forward-looking statements are expressed differently. You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other "forward-looking" information based on currently available information. Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things: (i) our ability to obtain adequate and timely rate increases on our supplemental health products including our long-term care business; (ii) mortality, morbidity, usage of health care services, persistency, the adequacy of our previous reserve estimates and other factors which may affect the profitability of our insurance products; (iii) changes in our assumptions related to the cost of policies produced or the value of policies inforce at the Effective Date; (iv) our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems; (v) performance of our investments; (vi) our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition; (vii) the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject; (viii) our ab
'/>"/>
SOURCE Conseco, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Conseco to Host Follow-Up Long-Term Care Conference Call
2. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
3. Conseco Completes Divestiture of Old Block of Fixed and Equity-Indexed Annuities
4. Conseco Sets Earnings Release Date
5. Conseco Reports Third Quarter Results
6. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
7. Additional Top Tier Institutions Implement Mediwares HCLL(TM) Transfusion Management Software
8. Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
9. Newton-Wellesley Hospital First in Massachusetts to Implement Isabel Diagnosis Decision Support System
10. AHIMA Signs Contract With CMS for ICD-10 Implementation Assessment and Training
11. Wild American Shrimp Board Agrees To Implement New Self-Funding Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
... Transplant Program, beset with administrative pro...tatement, The UCSD communicated its decision to re... liver and kidney transplants, of his administrati...l still continue as a full-time surgeon and member...
... been raised against a Food Standards Agency adver... consumption, without appropriate evidence. // An ...ection that a family involved in a salt-challenge ...uming less salt. Advertising Standards Authority...
...gland have stated that the proposed Government pla...s to 48 hours cannot be achieved without a substan...ition, an improvement in the health care facilitie...ave also been raised, requesting the local health ...
...Health Services (NHS) patients, currently on a six...following the Government report that would be rele...ated earlier that the maximum waiting period would...to be admitted to a hospital by the end of 2005. T...
Other Medicine News:Health News:Government Advertisement Faces Criticism For Wrong Salt Claim 2
(Date:10/6/2008)...with Durezol Dosed Prior to Surgery, TAMPA, Fla.,... a,privately held ophthalmic-focused biopharmaceut...fluprednate ophthalmic emulsion) 0.05% is now,comm... the U.S. Food and,Drug Administration in June 200...d for the treatment of inflammation and pain assoc...
(Date:10/6/2008)...e to severe patients achieved endoscopic,response ...sion at Week 10,in data from a 54-week open-label ...nterology (ACG) Annual Scientific Meeting, ORLAND...d data from a,large, prospective study investigati...with a biologic compound. The data presented at th...
(Date:10/6/2008)...stCall/ -- Dendreon Corporation (Nasdaq:,DNDN) wil... 2008 at 9:00 AM,ET (6:00 AM PT) to review the out...therapy for Prostate AdenoCarcinoma Treatment, als...sipuleucel-T), the Company,s investigational,activ...nced prostate,cancer., Those interested may ac...
(Date:10/3/2008)...s the newest study site, PHILADELPHIA, Oct. 3 /PR... Philadelphia today received a contract to manage ... Children,s Hospital will manage local,participati...County, New,Jersey. The study is funded by the Nat...pate approximately 1,000 families in Burlington,Co...
Breaking Medicine Technology:Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 1Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 2Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 3Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 4Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 5Abbott Receives FDA Approval for SIMCOR 28R 29 28Niaspan 28R 29 simvastatin 29 a Novel Combination Medicine for Comprehensive Cholesterol Manageme 3343 6Stress may increase a womans risk of developing cervical cancer 12083 1Stress may increase a womans risk of developing cervical cancer 12083 2Daily Stress May Raise Womens Risk of Cervical Cancer 12080 1Daily Stress May Raise Womens Risk of Cervical Cancer 12080 2Daily Stress May Raise Womens Risk of Cervical Cancer 12080 3A map of the worm 3A First detailed anatomical atlas of C elegans for use in the lab 12077 1A map of the worm 3A First detailed anatomical atlas of C elegans for use in the lab 12077 2
...ease Week -, CAMBRIDGE, Mass., May 21, 2007 /PRNew...n of data from a Phase 2 study in which,linaclotid...unction,in patients with constipation- predominant... showed linaclotide was well tolerated with,a low ...t-in-class,compound currently being developed for ...
...rom phase III,clinical trials and further human ph...ress of the European Academy of,Dermatology and Ve...acy and safety profile of alitretinoin as a potent...vere refractory chronic,hand eczema. , Currently, ...nd,Eczema (CHE) refractory or unresponsive to topi...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
Helmer's Horizon Series Plasma Storage Freezers HPF 125-4 incorporate solid performance and value. They feature a microprocessor-based independent temperature controller and alarm/monitor system with
Plasma Blast Chest Freezer -50C - 8098/8091 maintains a -50C (-58F) temperature to rapidly freeze single donor, apheresed, and fresh frozen plasma. Rapid freezing also preserves Factor VIII. Full loa
...for digital histology. It consists of a scanner, a...software modules. At the heart of MIRAX SCAN lies ...s Digital Slides. Any time, from any place. In bri...s on a microscope. The Digital Slide will revoluti...
... incorporates detection of T-wave alternans (TWA) ...nalysis tools. Premier 12 makes a complete 24-hour... provides visualization of the actual TWA, for vis... detects two modes of TWA: the beat-to-beat change...
Medicine Products: